These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11839145)

  • 1. Expression of CD4 controls the susceptibility of THP-1 cells to infection by R5 and X4 HIV type 1 isolates.
    Konopka K; Düzgüneş N
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):123-31. PubMed ID: 11839145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
    Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA
    J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
    Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
    Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
    Grivel JC; Margolis LB
    Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.
    Schweighardt B; Roy AM; Meiklejohn DA; Grace EJ; Moretto WJ; Heymann JJ; Nixon DF
    J Virol; 2004 Sep; 78(17):9164-73. PubMed ID: 15308712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa.
    Meng G; Sellers MT; Mosteller-Barnum M; Rogers TS; Shaw GM; Smith PD
    J Infect Dis; 2000 Sep; 182(3):785-91. PubMed ID: 10950772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
    Bunnik EM; Quakkelaar ED; van Nuenen AC; Boeser-Nunnink B; Schuitemaker H
    J Virol; 2007 Jan; 81(2):525-31. PubMed ID: 17079299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
    Lisco A; Grivel JC; Biancotto A; Vanpouille C; Origgi F; Malnati MS; Schols D; Lusso P; Margolis LB
    J Virol; 2007 Jan; 81(2):708-17. PubMed ID: 17065205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil.
    Ferraro GA; Mello MA; Sutmöller F; Van Weyenbergh J; Shindo N; Galvão-Castro B; Bou-Habib DC;
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1241-7. PubMed ID: 11559423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific reactions between purified HIV-1 particles and CD4+ cell membrane fragments in a cell-free system of virus fusion or entry.
    Harada T; Tatsumi M; Takahashi H; Sata T; Kurata T; Kojima A
    Microbes Infect; 2004 Apr; 6(5):421-8. PubMed ID: 15109956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells.
    Moonis M; Lee B; Bailer RT; Luo Q; Montaner LJ
    AIDS; 2001 Oct; 15(15):1941-9. PubMed ID: 11600821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection.
    Poles MA; Elliott J; Taing P; Anton PA; Chen IS
    J Virol; 2001 Sep; 75(18):8390-9. PubMed ID: 11507184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
    Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
    Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
    J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.
    Agrawal L; Lu X; Qingwen J; VanHorn-Ali Z; Nicolescu IV; McDermott DH; Murphy PM; Alkhatib G
    J Virol; 2004 Mar; 78(5):2277-87. PubMed ID: 14963124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective HIV-1-induced downmodulation of CD4 and coreceptors.
    Chenine AL; Sattentau Q; Moulard M
    Arch Virol; 2000; 145(3):455-71. PubMed ID: 10795515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.